PET/CT in the Staging of the Non-Small-Cell Lung Cancer

Lung cancer is a common disease and the leading cause of cancer-related death in many countries. Precise staging of patients with non-small-cell lung cancer plays an important role in determining treatment strategy and prognosis. Positron emission tomography/computed tomography (PET/CT), combining a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Fangfang, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346692/
https://www.ncbi.nlm.nih.gov/pubmed/22577296
http://dx.doi.org/10.1155/2012/783739
_version_ 1782232209672896512
author Chao, Fangfang
Zhang, Hong
author_facet Chao, Fangfang
Zhang, Hong
author_sort Chao, Fangfang
collection PubMed
description Lung cancer is a common disease and the leading cause of cancer-related death in many countries. Precise staging of patients with non-small-cell lung cancer plays an important role in determining treatment strategy and prognosis. Positron emission tomography/computed tomography (PET/CT), combining anatomic information of CT and metabolic information of PET, is emerging as a potential diagnosis and staging test in patients with non-small-cell lung cancer (NSCLC). The purpose of this paper is to discuss the value of integrated PET/CT in the staging of the non-small-cell lung cancer and its health economics.
format Online
Article
Text
id pubmed-3346692
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-33466922012-05-10 PET/CT in the Staging of the Non-Small-Cell Lung Cancer Chao, Fangfang Zhang, Hong J Biomed Biotechnol Review Article Lung cancer is a common disease and the leading cause of cancer-related death in many countries. Precise staging of patients with non-small-cell lung cancer plays an important role in determining treatment strategy and prognosis. Positron emission tomography/computed tomography (PET/CT), combining anatomic information of CT and metabolic information of PET, is emerging as a potential diagnosis and staging test in patients with non-small-cell lung cancer (NSCLC). The purpose of this paper is to discuss the value of integrated PET/CT in the staging of the non-small-cell lung cancer and its health economics. Hindawi Publishing Corporation 2012 2012-03-07 /pmc/articles/PMC3346692/ /pubmed/22577296 http://dx.doi.org/10.1155/2012/783739 Text en Copyright © 2012 F. Chao and H. Zhang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Chao, Fangfang
Zhang, Hong
PET/CT in the Staging of the Non-Small-Cell Lung Cancer
title PET/CT in the Staging of the Non-Small-Cell Lung Cancer
title_full PET/CT in the Staging of the Non-Small-Cell Lung Cancer
title_fullStr PET/CT in the Staging of the Non-Small-Cell Lung Cancer
title_full_unstemmed PET/CT in the Staging of the Non-Small-Cell Lung Cancer
title_short PET/CT in the Staging of the Non-Small-Cell Lung Cancer
title_sort pet/ct in the staging of the non-small-cell lung cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346692/
https://www.ncbi.nlm.nih.gov/pubmed/22577296
http://dx.doi.org/10.1155/2012/783739
work_keys_str_mv AT chaofangfang petctinthestagingofthenonsmallcelllungcancer
AT zhanghong petctinthestagingofthenonsmallcelllungcancer

Ejemplares similares